Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
FEBS Letters|February 16, 2005
Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycansOlga Vasiljeva, Marko Dolinar, Jerica Rozman Pungercar, et al.Biological Chemistry|March 27, 2019
The multifaceted roles of tumor-associated proteases and harnessing their activity for prodrug activationOlga Vasiljeva, Daniel R Hostetter, Stephen J Moore, et al.Pharmaceutics|October 28, 2023
A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin AAndreja Kozak, Georgy Mikhaylov, Pavlo Khodakivskyi, et al.Scientific Reports|April 5, 2020
Monitoring protease activity in biological tissues using antibody prodrugs as sensing probesOlga Vasiljeva, Elizabeth Menendez, Margaret Nguyen, et al.Current Pharmaceutical Design|February 22, 2007
Emerging roles of cysteine cathepsins in disease and their potential as drug targetsOlga Vasiljeva, Thomas Reinheckel, Christoph Peters, et al.Cells|February 26, 2026
Stefin B and Cystatin C Deficiency Suppresses Tumor Growth and Alters Tumor Microenvironment in a Breast Cancer ModelPetra Matjan Štefin, Janja Završnik, Miha Butinar, et al.Pharmaceutics|September 28, 2021
Novel Ex Vivo Zymography Approach for Assessment of Protease Activity in Tissues with Activatable AntibodiesBruce Howng, Michael B Winter, Carol LePage, et al.Biochimie|November 8, 2015
In vivo imaging of protease activity by Probody therapeutic activationKenneth R Wong, Elizabeth Menendez, Charles S Craik, et al.Biochimica Et Biophysica Acta|October 26, 2011
Cysteine cathepsins: from structure, function and regulation to new frontiersVito Turk, Veronika Stoka, Olga Vasiljeva, et al.FEBS Letters|January 28, 2014
Decreased IL-10 expression in stefin B-deficient macrophages is regulated by the MAP kinase and STAT-3 signaling pathwaysKatarina Maher, Janja Završnik, Barbara Jerič-Kokelj, et al.Pageof 5